August 9, 2026
A New Frontier: The Center for Therapeutic Genetics Aims to Turn Rare Disease "One-Offs" Into Repeatable Medicine a-new-frontier-the-center-for-therapeutic-genetics-aims-to-turn-rare-disease-one-offs-into-repeatable-medicine

A New Frontier: The Center for Therapeutic Genetics Aims to Turn Rare Disease "One-Offs" Into Repeatable Medicine

Asep Darmawan July 21, 2026
In a landmark move that promises to reshape the landscape of modern medicine, three of the world’s...
Read More Read more about A New Frontier: The Center for Therapeutic Genetics Aims to Turn Rare Disease "One-Offs" Into Repeatable Medicine
A Decade of Hope: Landmark Penn Medicine Study Suggests Potential Cures for Lymphoma via CAR T Cell Therapy a-decade-of-hope-landmark-penn-medicine-study-suggests-potential-cures-for-lymphoma-via-car-t-cell-therapy

A Decade of Hope: Landmark Penn Medicine Study Suggests Potential Cures for Lymphoma via CAR T Cell Therapy

Azzam Bilal Chamdy July 21, 2026
In a milestone for modern oncology, long-term follow-up data from one of the earliest clinical trials of...
Read More Read more about A Decade of Hope: Landmark Penn Medicine Study Suggests Potential Cures for Lymphoma via CAR T Cell Therapy
Unraveling the Heart of the Matter: New Research Sheds Light on Hormone Therapy’s Long-Term Cardiovascular Impact unraveling-the-heart-of-the-matter-new-research-sheds-light-on-hormone-therapys-long-term-cardiovascular-impact

Unraveling the Heart of the Matter: New Research Sheds Light on Hormone Therapy’s Long-Term Cardiovascular Impact

Raul Delapena Setiawan July 21, 2026
Main Facts The decision to initiate hormone therapy (HT) during the menopause transition, a pivotal life phase...
Read More Read more about Unraveling the Heart of the Matter: New Research Sheds Light on Hormone Therapy’s Long-Term Cardiovascular Impact
The Economics of Constraint: How Most-Favored-Nation Pricing is Rewriting the Generic Drug Playbook the-economics-of-constraint-how-most-favored-nation-pricing-is-rewriting-the-generic-drug-playbook

The Economics of Constraint: How Most-Favored-Nation Pricing is Rewriting the Generic Drug Playbook

Nana Muazin July 21, 2026
The pharmaceutical landscape in the United States is undergoing a profound structural metamorphosis. As federal regulators and...
Read More Read more about The Economics of Constraint: How Most-Favored-Nation Pricing is Rewriting the Generic Drug Playbook

You may have missed

the-great-retrenchment-assessing-the-impact-of-the-trump-administrations-foreign-aid-overhaul

The Great Retrenchment: Assessing the Impact of the Trump Administration’s Foreign Aid Overhaul

Basiran August 9, 2026
beyond-the-surface-the-critical-imperative-of-precision-wound-care

Beyond the Surface: The Critical Imperative of Precision Wound Care

Lina Hope August 9, 2026
breakthrough-in-brain-cancer-usc-researchers-uncover-potent-combination-therapy-for-glioblastoma

Breakthrough in Brain Cancer: USC Researchers Uncover Potent Combination Therapy for Glioblastoma

Ali Ikhwan August 9, 2026
post-covid-complications-new-research-links-prior-infection-to-increased-blood-clot-risks-in-panniculectomy-patients

Post-COVID Complications: New Research Links Prior Infection to Increased Blood Clot Risks in Panniculectomy Patients

Ammar Sabilarrohman August 9, 2026